Correlation Between Knight Therapeutics and Brompton European

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Brompton European at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Brompton European into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and Brompton European Dividend, you can compare the effects of market volatilities on Knight Therapeutics and Brompton European and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Brompton European. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Brompton European.

Diversification Opportunities for Knight Therapeutics and Brompton European

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Knight and Brompton is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Brompton European Dividend in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brompton European and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Brompton European. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brompton European has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Brompton European go up and down completely randomly.

Pair Corralation between Knight Therapeutics and Brompton European

Assuming the 90 days trading horizon Knight Therapeutics is expected to generate 1.66 times more return on investment than Brompton European. However, Knight Therapeutics is 1.66 times more volatile than Brompton European Dividend. It trades about 0.22 of its potential returns per unit of risk. Brompton European Dividend is currently generating about 0.2 per unit of risk. If you would invest  523.00  in Knight Therapeutics on October 22, 2024 and sell it today you would earn a total of  25.00  from holding Knight Therapeutics or generate 4.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Knight Therapeutics  vs.  Brompton European Dividend

 Performance 
       Timeline  
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Brompton European 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brompton European Dividend has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Brompton European is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Knight Therapeutics and Brompton European Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Knight Therapeutics and Brompton European

The main advantage of trading using opposite Knight Therapeutics and Brompton European positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Brompton European can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brompton European will offset losses from the drop in Brompton European's long position.
The idea behind Knight Therapeutics and Brompton European Dividend pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges